HDL enhances oxidation of LDL in vitro in both men and women

Lipids in Health and Disease

Volumn 4, Issue , 2005, Pages

  Solakivi, T ^a   Jaakkola, O ^b   Salomaki A ^c   Peltonen, N ^c   Metso, S ^c   Lehtimaki T ^c   Jokela, H ^c   Nikkari, S T ^a,c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OLEIC ACID;

ADULT; ARTICLE; ATHEROGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATION; SEX RATIO;

ADULT; COPPER; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, HDL2; LIPOPROTEINS, HDL3; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 28044473630     PISSN: 1476511X     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-4-25     Document Type: Article

References (40)

1. Nikkilä EA: Letter: Serum high-density-lipoprotein and coronary heart-disease. Lancet 1976, 2:320.
2. Sviridov D, Nestel P: Dynamics of reverse cholesterol transport: protection against atherosclerosis. Atherosclerosis 2002, 161:245-254.
3. Parthasarathy S, Barnett J, Fong LG: High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1990, 1044:275-283.
4. Bowry VW, Stanley KK, Stocker R: High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc Natl Acad Sci USA 1992, 89:10316-10320.
5. La Ville AE, Sola R, Balanya J, Turner PR, Masana L: In vitro oxidised HDL is recognised by the scavenger receptor of macrophages: implications for its protective role in vivo. Atherosclerosis 1994, 105:179-189.
6. Navab M, Hama SY, Reddy ST, Ng CJ, Van Lenten BJ, Laks H, Fogelman AM: Oxidized lipids as mediators of coronary heart disease. Curr Opin Lipidol 2002, 13:363-372.
7. Nakajima T, Origuchi N, Matsunaga T, Kawai S, Hokari S, Nakamura H, Inoue I, Katayama S, Nagata A, Komoda T: Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Ann Clin Biochem 2000, 37:179-186.
8. Nagano Y, Arai H, Kita T: High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 1991, 88:6457-6461.
9. Raveh O, Pinchuk I, Schnitzer E, Fainaru M, Schaffer Z, Lichtenberg D: Kinetic analysis of copper-induced peroxidation of HDL, autoaccelerated and tocopherol-mediated peroxidation. Free Rad Biol Med 2000, 29:131-146.
10. Suzukawa M, Ishikawa T, Yoshida H, Nakamura HJ: Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 1995, 14:46-52.
11. Schnitzer E, Pinchuk I, Fainaru M, Schafer Z, Lichtenberg D: Copper-induced lipid oxidation in unfractionated plasma: the lag preceding oxidation as a measure of oxidation-resistance. Biochem Biophys Res Commun 1995, 216:854-861.
12. Ohmura H, Watanabe Y, Hastumi C, Sato H, Daida H, Mokuno H, Yamaguchi H: Possible role of high susceptibility of high-density lipoprotein to lipid peroxidative modification and oxidized high-density lipoprotein in genesis of coronary artery spasm. Atherosclerosis 1999, 142:179-184.
13. Mackness MI, Durrington PN: HDL, its enzymes and its potential to influence lipid peroxidation. Atherosclerosis 1995, 115:243-253.
14. Tribble DL, Chu BM, Gong EL, Van-Venrooij F, Nichols AV: HDL antioxidant effects as assessed using a nonexchangeable probe to monitor particle-specific peroxidative stress in LDL-HDL mixtures. J Lipid Res 1995, 36:2580-2589.
15. Kunitake ST, Jarvis MR, Hamilton RL, Kane JP: Binding of transition metals by apolipoprotein A-I-containing plasma lipoproteins: inhibition of oxidation of low density lipoproteins. Proc Natl Acad Sci USA 1992, 89:6993-6997.
16. Kontush A, Chantepie S, Chapman MJ: Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress. Arterioscler Thromb Vasc Biol 2003, 23:1881-1888.
17. Ziouzenkova O, Gieseg SP, Ramos P, Esterbauer H: Factors affecting resistance of low density lipoproteins to oxidation. Lipids 1996:S71-76.
18. Gieseg SP, Esterbauer H: Low density lipoprotein is saturable by pro-oxidant copper. FEBS Lett 1994, 343:188-194.
19. Abbey M, Nestel PJ, Baghurst PA: Antioxidant vitamins and lowdensity lipoprotein oxidation. Am J Clin Nutr 1993, 58:525-532.
20. Goulinet S, Chapman MJ: Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol 1997, 17:786-796.
21. Reaven PD, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL: Effects of oleate-rich and linoleate-rich diets on the susceptibility of low-density lipoproteins to modification in mildly hypercholesterolemic volunteers. J Clin Invest 1993, 91:668-676.
22. Schnell JW, Anderson RA, Stegner JE, Schindler SP, Weinberg RB: Effects of high polyunsaturated fat diet and vitamin E on high-density lipoprotein oxidation in humans. Atherosclerosis 2001, 159:459-466.
23. Chait A, Brazg RL, Tribble DL, Krauss RM: Susceptibility of small, dense low-density lipoproteins to oxidative modification in volunteers with the atherogenic lipoprotein phenotype, Pattern B. Am J Med 1993, 94:350-356.
24. Korpela R, Seppo L, Laakso J, Lilja J, Karjala K, Lähteenmäki T, Solatunturi E, Vapaatalo H, Tikkanen MJ: Dietary habits affect the susceptibility of low-density lipoprotein to oxidation. Eur J Clin Nutr 1999, 52:802-807.
25. Lambert AJ, Portero-Otin M, Pamplona R, Merry BJ: Effect of ageing and caloric restriction on specific markers of protein oxidative damage and membrane peroxidizability in rat liver mitochondria. Mech Ageing Dev 2004, 125:529-538.
26. Pinchuk I, Schnitzer E, Lichtenberg D: Kinetic analysis of copperinduced peroxidation of LDL. Biochim Biophys Acta 1998, 1389:155-172.
27. Bonanome A, Pagnan A, Biffanti S, Opportuno A, Sorgato F, Dorella M, Maiorino M, Ursini F: Effect of monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arterioscler Thromb 1992, 12:529-533.
28. Kleinveld HA, Naber AH, Stalenhoef AF, Demacker PN: Oxidation resistance, oxidation rate and extent of oxidation of human low-density lipoprotein depend on the ratio of oleic acid content to linoleic acid content: Studies in vitamin E deficient subjects. Free Rad Biol Med 1993, 15:273-280.
29. Scheffer PG, Bakker SJ, Popp-Snijders C, Heine RJ, Schulgens RB, Teerlink T: Composition of LDL as determinant of its susceptibility to in vitro oxidation in patients with well-controlled type 2 diabetes. Diabetes Metab Res Rev 2001, 17:459-466.
30. Tsai EC, Hirsch IB, Brunzell JD, Chait A: Reduced plasma peroxyltrapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994, 43:1010-1014.
31. Jenkins AJ, Thorpe SR, Alderson NL, Hermayer KL, Lyons TJ, King LP, Chassereau CN, Klein RL: In vivo glycated low-density lipoprotein is not more susceptible to oxidation than nonglycated low-density lipoprotein in type I diabetes. Metabolism 2004, 53:969-976.
32. Ramos P, Gieseg SP, Schuster B, Esterbauer H: Effect of temperature and phase transition on oxidation resistance of low density lipoprotein. J Lipid Res 1995, 36:2113-2128.
33. Jaakkola O, Solakivi T, Tertov VV, Orekhov AN, Miettinen TA, Nikkari T: Characteristics of low-density lipoprotein subfractions from patients with coronary artery disease. Coronary Artery Dis 1993, 4:379-385.
34. Leinonen JS, Rantalaiho V, Solakivi T, Koivula T, Wirta O, Pasternack A, Alho H, Lehtimäki T: Susceptibility of LDL to oxidation is not associated with the presence of coronary heart disease or renal dysfunction in NIDDM patients. Clin Chim Acta 1998, 275:163-174.
35. Esterbauer H, Striegl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun 1989, 6:67-75.
36. Markwell MA, Haas SM, Tolbert NE, Bieber LL: Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods Enzymol 1981, 72:296-303.
37. Jaakkola O, Solakivi T, Ylä-Herttuala S, Nikkari T: Receptor-mediated binding and degradation of subfractions of human plasma low-density lipoprotein in cultured fibroblasts. Biochim Biophys Acta 1989, 1005:118-122.
38. Krauss RM, Burke DJ: Identification of multiple subfractions of plasma low density lipoproteins in normal humans. J Lipid Res 1982, 23:97-104.
39. Siirtola A, Antikainen M, Ala-Houhala M, Solakivi T, Jokela H, Lehtimäki T, Holmberg C, Salo MK: Studies of LDL particle size and susceptibility to oxidation and association with glucose metabolism in children after heart transplantation. J Heart Lung Transplant 2004, 23:418-426.
40. Folch J, Lees M, Stanley GHS: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 66:375-400.